A Glanzmann’s mutation in β3 integrin specifically impairs osteoclast function
Open accessThe DOI matches its Crossref record.
Abstract
Osteoclastic bone resorption requires cell-matrix contact, an event mediated by the alpha v beta 3 integrin. The structural components of the integrin that mediate osteoclast function are, however, not in hand. To address this issue, we generated mice lacking the beta 3 integrin gene, which have dysfunctional osteoclasts. Here, we show the full rescue of beta 3(-/-) osteoclast function following expression of a full-length beta 3 integrin. In contrast, truncated beta 3, lacking a cytoplasmic domain (h beta 3c), is completely ineffective in restoring function to beta 3(-/-) osteoclasts. To identify the components of the beta 3 cytoplasmic domain regulating osteoclast function, we generated six point mutants known, in other circumstances, to mediate beta integrin signaling. Of the six, only the S(752)P substitution, which also characterizes a form of the human bleeding disorder Glanzmann's thrombasthenia, fails to rescue beta 3(-/-) osteoclasts or restore ligand-activated signaling in the form of c-src activation. Interestingly, the double mutation Y(747)F/Y(759)F, which disrupts platelet function, does not affect the osteoclast. Thus similarities and distinctions exist in the mechanisms by which the beta 3 integrin regulates platelets and osteoclasts.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Genetic regulation of osteoclast development and function
Teitelbaum, S. L., & Ross, F. P. (2003) · Nature Reviews Genetics · doi:10.1038/nrg1122 · Cited by 1,701
Self-citationAutologous platelets as a source of proteins for healing and tissue regeneration
Anitua, E., Andia, I., Ardanza, B., Nurden, P., & Nurden, A. (2004) · Thrombosis and Haemostasis · doi:10.1160/th03-07-0440 · Cited by 1,495
Adhesion signaling – crosstalk between integrins, Src and Rho
Huveneers, S., & Danen, E. H. J. (2009) · Journal of Cell Science · doi:10.1242/jcs.039446 · Cited by 852
Osteoclasts: What Do They Do and How Do They Do It?
Teitelbaum, S. L. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.060834 · Cited by 730
Self-citationThe integrin adhesome: from genes and proteins to human disease
Winograd-Katz, S. E., Fässler, R., Geiger, B., & Legate, K. R. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3769 · Cited by 623
Src kinase activation by direct interaction with the integrin β cytoplasmic domain
Arias-Salgado, E. G., Lizano, S., Sarkar, S., Brugge, J. S., Ginsberg, M. H., & Shattil, S. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2336149100 · Cited by 554
Xu, F., & Teitelbaum, S. L. (2013) · Bone Research · doi:10.4248/br201301003 · Cited by 523
Self-citationObergfell, A., Eto, K., Mocsai, A., Buensuceso, C., Moores, S. L., Brugge, J. S., Lowell, C. A., & Shattil, S. J. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200112113 · Cited by 410
The Osteoclast: Friend or Foe?
Novack, D. V., & Teitelbaum, S. L. (2008) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathmechdis.3.121806.151431 · Cited by 381
Self-citationNitrated Fatty Acids: Endogenous Anti-inflammatory Signaling Mediators
Cui, T., Schopfer, F. J., Zhang, J., Chen, K., Ichikawa, T., Baker Paul, R. S., Batthyany, C., Chacko, B. K., Feng, X., Patel, R. P., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603357200 · Cited by 351
Self-citationA point mutation in KINDLIN3 ablates activation of three integrin subfamilies in humans
Malinin, N. L., Zhang, L., Choi, J., Ciocea, A., Razorenova, O., Ma, Y.-Q., Podrez, E. A., Tosi, M., Lennon, D. P., Caplan, A. I., et al. (2009) · Nature Medicine · doi:10.1038/nm.1917 · Cited by 341
αvβ3and macrophage colony‐stimulating factor: partners in osteoclast biology
Ross, F. P., & Teitelbaum, S. L. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00331.x · Cited by 303
Self-citationExtracellular matrix networks in bone remodeling
Alford, A. I., Kozloff, K. M., & Hankenson, K. D. (2015) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2015.05.008 · Cited by 300
Zou, W., Kitaura, H., Reeve, J., Long, F., Tybulewicz, V. L. J., Shattil, S. J., Ginsberg, M. H., Ross, F. P., & Teitelbaum, S. L. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200611083 · Cited by 288
Self-citationVav3 regulates osteoclast function and bone mass
Faccio, R., Teitelbaum, S. L., Fujikawa, K., Chappel, J., Zallone, A., Tybulewicz, V. L., Ross, F. P., & Swat, W. (2005) · Nature Medicine · doi:10.1038/nm1194 · Cited by 282
Self-citationAsano, Y., Ihn, H., Yamane, K., Jinnin, M., Mimura, Y., & Tamaki, K. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.11.7708 · Cited by 231
Molecular regulation of osteoclast activity
Bruzzaniti, A., & Baron, R. (2006) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-006-9009-x · Cited by 173
“Osteoclasts isolated from these mice fail to spread normally, exhibit a disrupted actin ring and abnormal ruffled border, resulting in dysfunctional resorptive activity [43, 44].”
BackgroundPhospholipase Cγ2 Mediates RANKL-stimulated Lymph Node Organogenesis and Osteoclastogenesis
Chen, Y., Wang, X., Di, L., Fu, G., Chen, Y., Bai, L., Liu, J., Feng, X., McDonald, J. M., Michalek, S., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802493200 · Cited by 27
Self-citation
Metadata
- Authors
- Feng, X., Novack, D. V., Faccio, R., Ory, D. S., Aya, K., Boyer, M. I., McHugh, K. P., Ross, F. P., & Teitelbaum, S. L.
- Venue
- Journal of Clinical Investigation
- Published
- 2001-05-01
- Volume
- 107
- Issue
- 9
- Pages
- 1137-1144
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2102542260
- Cited by
- 134
- References
- 0
- FWCI
- 4.36
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.